GLASS分期对慢性肢体威胁性缺血的预后价值及血运重建策略的系统综述与荟萃分析
该系统综述与荟萃分析纳入17项研究、5290例患者共5492条肢体,评估GLASS分期在慢性肢体威胁性缺血中的预后价值。结果显示GLASS解剖复杂度增加与内血管干预即刻技术成功率降低及肢体通畅失败风险升高相关;在GLASS III患者中,内血管治疗较开放旁路手术与主要不良肢体事件风险增加相关。
要点
- GLASS分期越高,内血管干预即刻技术成功率越低,肢体通畅失败风险越高
- GLASS III较GLASS I的全因死亡、MALE及肢体通畅失败风险均显著升高
- GLASS III患者中,内血管治疗较开放旁路手术的MALE风险更高
核心结论
- GLASS解剖严重度增加与内血管干预即刻技术成功率降低及所有血运重建策略下肢体通畅失败风险升高相关。
- GLASS I低复杂度解剖患者的死亡和MALE风险低于GLASS III高复杂度疾病患者。
- GLASS III患者中,内血管治疗较旁路手术与MALE风险增加相关。
研究设计与样本
- 纳入17项研究,共5290例患者、5492条肢体:GLASS I 945条(17.2%)、GLASS II 1431条(26.1%)、GLASS III 3116条(56.7%)。
主要发现
- 内血管与外科旁路血运重建在其他结局上无显著差异。
临床怎么用
- 可将GLASS分期用于慢性肢体威胁性缺血患者的解剖复杂度分层与预后评估。
- 对GLASS III患者选择血运重建方式时,需权衡内血管治疗MALE风险较高与旁路手术的其他因素。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To perform a systematic review and meta-analysis evaluating the prognostic utility of the Global Limb Anatomical Staging System (GLASS) classification in patients with chronic limb-threatening ischemia, and to determine which intervention, endovascular or open bypass, is associated with superior outcomes in patients classified as GLASS III. METHODS: We conducted a systematic review and meta-analysis using PubMed, Scopus, and Cochrane Central from inception through October 2025. Outcomes compared across GLASS stages included immediate technical success (ITS) of endovascular procedures, overall survival, amputation-free survival, limb salvage, freedom from major adverse limb events (MALE), and limb-based patency (LBP). For patients with GLASS III disease, we directly compared endovascular vs surgical bypass revascularization for overall survival, freedom from MALE, and limb salvage. RESULTS: We included 17 studies in the meta-analysis, comprising 5290 patients and 5492 limbs: 945 (17.2%) GLASS I, 1431 (26.1%) GLASS II, and 3116 (56.7%) GLASS III. Compared with GLASS I, GLASS II presented a significantly higher hazard for LBP failure [hazard ratio (HR), 1.53; 95% confidence interval (CI), 1.06-2.20; P = .032] and major amputation (endovascular only; HR, 1.45; 95% CI, 1.13-1.86). When comparing GLASS III with GLASS I, GLASS III had significantly higher hazard for mortality (HR, 1.28; 95% CI, 1.06-1.56; P = .021), MALE (HR, 1.36; 95% CI, 1.02-1.83; P = .042), and LBP failure (HR, 2.23; 95% CI, 1.56-3.19; P = .003). GLASS I presented a significantly higher ITS rate compared with GLASS II [risk ratio (RR), 1.03; 95% CI, 1.01-1.05; P = .016] and GLASS III (RR, 1.24; 95% CI, 1.09-1.41; P = .005). GLASS II also showed a significantly higher ITS rate compared with GLASS III (RR, 1.20; 95% CI, 1.04-1.38; P = .017). No other comparisons across GLASS stages were statistically significant. Among patients classified as GLASS III, we found an increased hazard of MALE in the endovascular group compared with open bypass surgery (HR, 1.88; 95% CI, 1.35-2.61; P = .015). No significant differences were identified between endovascular and surgical bypass revascularization for other outcomes. CONCLUSIONS: This meta-analysis demonstrates that increasing GLASS anatomical severity is associated with progressively lower ITS following endovascular intervention and increased hazard of LBP failure across all revascularization strategies in patients with chronic limb-threatening ischemia. Patients classified as GLASS I, with low complexity anatomies, had a lower mortality and MALE hazard compared with those with high-complexity disease (GLASS III). Among patients classified as GLASS III, endovascular therapy is associated with an increased hazard for MALE compared with bypass surgery.
引用
- Melo CB, Pimentel-Junior D, Obara MK, et al. A systematic review and meta-analysis of prognosis and revascularization strategies in chronic limb-threatening ischemia according to the global limb anatomical staging system. J Vasc Surg. 2026. PMID: 42546857. doi:10.1016/j.jvs.2026.07.079
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。